Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IGL (Jamaica) Limited is the leading provider of industrial and medical gases in Jamaica, serving as the island's sole manufacturer of medical-grade oxygen. The company plays a critical role in the healthcare sector by supplying essential gases, including nitrous oxide, nitrogen, and carbon dioxide, to hospitals, dental clinics, and emergency medical services. Beyond its healthcare portfolio, IGL is a dominant distributor of Liquefied Petroleum Gas (LPG) under the IGL Blue brand, supporting residential and commercial energy needs across the country. In 2023, the company was acquired by IGL Blue Limited, a subsidiary of the InterEnergy Group, marking a major transition in its corporate ownership. IGL continues to operate as a vital infrastructure provider, maintaining extensive manufacturing and distribution facilities to support Jamaica's medical and energy requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IGL Blue Jamaica.